PRS smashes its own record for the fourth time in five years By Paul Snyder
T
he influence and impact of PRS continues to grow. The benchmarking and analytics tool InCites in June released its 2021 Journal Citation Report, revealing that PRS bested the 4.209 Impact Factor from last year that had, until this year’s 4.730 Impact Factor, been its highest mark. A journal’s Impact Factor is a measure of how frequently the average article in the publication is cited throughout scientific literature during the year (calculated by dividing the number of citations in a year by the total number of articles published in the two previous years). Of 210 total journals in the “surgery” category, PRS ranks 29 – the highest entry for any plastic surgery-focused publication – and again it’s the No. 1 plastic surgery journal in the world. The milestone is significant not only in the sense that it marks the fourth record-breaking Impact Factor in the past five years, but it’s also the fifth consecutive year that PRS topped 30,000 total citations. In fact, in the past year, PRS was cited more than 45,600 times. “This is not only phenomenal news, it’s also a quantum leap in terms of the influence that PRS enjoys as the specialty’s most respected journal,” says PRS Editor-in-Chief Rod Rohrich, MD. “It’s a reflection of the hard work of the authors, editors, reviewers, editorial board and staff, without whom we simply wouldn’t have this success. Considering the number of submissions we see every year, we have a very low acceptance rate, but the quality of content that’s printed in PRS makes the journal what it is. This is the motherlode for plastic surgery.” Although an Impact Factor is not the only metric upon which a journal’s quality and content is based, it remains an important gauge in determining influence. Authors, readers and advertisers consider Impact Factor scores in selecting which journals to work with or read. As in recent years, several of the most-cited articles from PRS focused on topics relating to breast implants
– including breast implant illness, BIA-ALCL, capsular contracture and reconstruction. However, articles relating to gender inequality and lower-extremity trauma reconstruction also gained a lot of attention. “The increase in the PRS Impact Factor over the past five years indicates the academic relevance and influence of the articles published in the white journal – not only in plastic surgery, but also over a broad spectrum of both surgical and nonsurgical specialties that focus on reconstructive and cosmetic issues,” says James Stuzin, MD, co-editor of PRS. “This year’s increase reflects the ever-increasing breadth of interest that remains the focus of PRS.” Kevin C. Chung, MD, MS, who will succeed Dr. Rohrich as PRS editor-in-chief next year, says he looks forward to embracing the challenge of keeping PRS in the upper echelon of medical journals. “I’m gratified to see the continued increase in our Impact Factor, which is a testament to the confidence of authors in submitting their best work to us,” Dr. Chung says. “PRS belongs in the select list of elite surgical journals. As I assume the editor-in-chief position in January, I will work closely with the editorial board to maintain the highest quality of publications for our worldwide, expanding readership.” Dr. Rohrich says that it’s a pleasure to end his term as the journal’s editor-in-chief on a prestigious high note, but he’s more proud – and grateful to everyone with whom he worked – to cement the importance of plastic surgery research in the larger academic field. “Former PRS Editor-in-Chief Robert Goldwyn, MD, gave me one piece of advice when I was coming in – and that was to nourish the baby and let it grow. ‘Do that,’ he told me, ‘and it will be strong and healthy.’ I’m proud of where the journal is now; it’s really come into its own in the scope of academic medicine. The science of what we do matters around the world – and I’m sure that influence will continue to grow in the future.” PSN
Register now for the Close the Loop 5K
T
July/August 2021
(listed alphabetically) Breast Implant Illness: A Way Forward. Magnusson, Mark R.; Cooter, Rod D.; Rakhorst, Hinne; McGuire, Patricia A.; Adams, William P. Jr; Deva, Anand K. Complications and Patient-Reported Outcomes after Abdominally Based Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study. Erdmann-Sager, Jessica; Wilkins, Edwin G.; Pusic, Andrea L.; Qi, Ji; Hamill, Jennifer B.; Kim, Hyungjin Myra; Guldbrandsen, Gretchen E.; Chun, Yoon S. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Collett, David J.; Rakhorst, Hinne; Lennox, Peter; Magnusson, Mark; Cooter, Rodney; Deva, Anand K. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Magnusson, Mark; Beath, Kenneth; Cooter, Rodney; Locke, Michelle; Prince, H. Miles; Elder, Elisabeth; Deva, Anand K. The Functional Influence of Breast Implant Outer Shell Morphology on Bacterial Attachment and Growth. Jones, Phoebe; Mempin, Maria; Hu, Honghua; Chowdhury, Durdana; Foley, Matthew; Cooter, Rodney; Adams, William P. Jr; Vickery, Karen; Deva, Anand K. Gender Inequality for Women in Plastic Surgery: A Systematic Scoping Review. Bucknor, Alexandra; Kamali, Parisa; Phillips, Nicole; Mathijssen, Irene; Rakhorst, Hinne; Lin, Samuel J.; Furnas, Heather How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma. Clemens, Mark W.; Brody, Garry S.; Mahabir, Raman C.; Miranda, Roberto N. Muscle versus Fasciocutaneous Free Flaps in Lower Extremity Traumatic Reconstruction: A Multicenter Outcomes Analysis. Cho, Eugenia H.; Shammas, Ronnie L.; Carney, Martin J.; Weissler, Jason M.; Bauder, Andrew R.; Glener, Adam D.; Kovach, Stephen J.; Hollenbeck, Scott T.; Levin, L. Scott A Prospective Comparison of Short-Term Outcomes of Subpectoral and Prepectoral Strattice-Based Immediate Breast Reconstruction. Baker, Benjamin G.; Irri, Renu; MacCallum, Vivienne; Chattopadhyay, Rahul; Murphy, John; Harvey, James R. Risk Factor Analysis for Capsular Contracture: A 10-Year Sientra Study Using Round, Smooth, and Textured Implants for Breast Augmentation. Calobrace, M. Bradley; Stevens, W. Grant; Capizzi, Peter J.; Cohen, Robert; Godinez, Tess; Beckstrand, Maggi
Leeches
When arterial inflow exceeds venous outflow. When venous return is a problem, the Hirudo Medicinalis can help provide the solution. Call Leeches U.S.A. and get an immediate, Door to Door, delivery of leeches. Efficacy, too • Provide the strongest anticoagulant known to man. • Provide temporary outflow of blood until the body restores venous ingrowth to the affected tissue. References: Pickrell BB, Daly MC, Freniere B, Higgins JP, Safa B, Eberlin KR. Leech Therapy Following Digital Replantation and Revascularization. J Hand Surg Am. 2020 Jul;45(7):638-643. doi: 10.1016/j.jhsa.2020.03.026. Epub 2020 May 31. PMID: 32493632.
Arami A, Gurevitz S, Palti R, Menachem S, Berelowitz M, Yaffe B. The Use of Medicinal Leeches for the Treatment of Venous Congestion in Replanted or Revascularized Digits. J Hand Surg Am. 2018 Oct;43(10):949.e1-949.e5. doi: 10.1016/j.jhsa.2018.02.018. Epub 2018 Mar 27. PMID: 29602653.
Herlin C, Bertheuil N, Bekara F, Boissiere F, Sinna R, Chaput B. Leech therapy in flap salvage: Systematic review and practical recommendations. Ann Chir Plast Esthet. 2017 Apr;62(2):e1-e13. doi: 10.1016/j. anplas.2016.06.004. Epub 2016 Jul 15. PMID: 27427444.
Immediate/Overnight Shipment
Monday - Thursday, 9 a.m. - 4:00 p.m. (EST)
1.800.645.3569
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC. Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction. Microsurgery. 2014 Oct;34(7):522-6. doi: 10.1002/micr.22277. Epub 2014 May 22. PMID: 24848693.
Nguyen MQ, Crosby MA, Skoracki RJ, Hanasono MM. Outcomes of flap salvage with medicinal leech therapy. Microsurgery. 2012 Jul;32(5):351-7. doi: 10.1002/ micr.21960. Epub 2012 Mar 31. PMID: 22473683.
Emergency Delivery Service in USA Fridays, After Hours, Weekends, Holidays.
1.800.473.4673
All other times see Emergency Delivery Service
In Canada, call 1.877.373.9222
Immediate shipping on the next available flight.
Immediate shipping on the next available flight.
300 Shames Drive, Westbury, NY 11590 U.S.A. • 516.333.2570 • 1.800.645.3569 • Fax: 516.997.4948 www.leechesusa.com
© Leeches USA 2021
his year’s Breast Reconstruction Awareness Close the Loop 5K will be held during Plastic Surgery The Meeting 2021 in Atlanta – but you (and your friends and family) can participate from wherever you are anytime between now and Oct. 31. The Close the Loop 5K will conclude Sunday, Oct. 31 at 9:30 a.m. (Halloween costumes are encouraged.) All winners will be recognized during the annual meeting’s Closing Ceremonies. In 2020, the Close the Loop 5K concluded with more than 320 participants and 30 teams raising more $100K for Breast Reconstruction Awareness. Even if you don’t plan on attending Plastic Surgery The Meeting, you can still participate in the 2021 Breast Reconstruction Awareness Close the Loop Virtual 5K. Register for the Close the Loop 5K or donate to the Breast Reconstruction Awareness Campaign as a virtual participant at https://p2p.onecause.com/bra5k. You can also register as a member of a team (no limit on team size), team captain or create a new team. Take part not only in a great event, but a way to educate, engage and empower women to make the decision that is best for them following a diagnosis with breast cancer. PSN
Top 10 most-cited PRS articles from the past two years
9
